IP Library › Granted Patent US 10,829,775
Granted Patent B2
US 10,829,775 · App. 16/405,440 · Granted Nov 10, 2020

Materials and methods for increasing the tocopherol content in seed oil

Inventor: Carl Andre (Research Triangle Park, NC)
Assignee: BASF PLANT SCIENCE COMPANY GMBH
C12N15/8247A61K31/202A61K36/31C12N9/0071C12N9/93C12Q1/6895C12Y114/19C12Y114/19003C12Y114/19006C12Y602/01003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,829,775
App. No.
16/405,440
Granted
Nov 10, 2020
Kind
B2
Abstract

The present invention relates generally to the field of molecular biology and concerns increasing the tocopherol content of a plant relative to a control plant, comprising expressing in a plant at least one polynucleotide encoding a delta-12-desaturase, at least one polynucleotide encoding a delta-6-desaturase, at least one polynucleotide encoding a delta-6-elongase, and at least one polynucleotide encoding a delta-5-desaturase. The present invention also relates to methods for the manufacture of oil, fatty acid- or lipids-containing compositions, and to such oils and lipids as such.

Claims (13)

1. A transgenic seed of a transgenic Brassica plant, the transgenic seed comprising tocopherol and n-3 very long chain polyunsaturated fatty acids (VLC-PUFAs), wherein the transgenic seed has increased total tocopherol content and increased n-3 VLC-PUFAs content as compared to a seed from a wild-type control Brassica plant of the same species and variety, wherein the increased n-3 VLC-PUFAs content comprises EPA and/or DHA; wherein the increased total tocopherol content and the increased n=3 VLC-PUFAs content in the transgenic seed of the transgenic Brassica plant are positively correlated, wherein the transgenic seed comprises transgenes which comprise at least one recombinant polynucleotide encoding a delta-12-desaturase from Phythophthora species, at least one recombinant polynucleotide encoding a delta-6-desaturase from Ostreococcus species, at least one recombinant polynucleotide encoding a delta-6-elongase from Physcomitrella species or Thalassiosira species, at least one recombinant polynucleotide encoding a delta-5-desaturase from Thraustochytrium species, at least one recombinant polynucleotide encoding a delta-5-elongase from Ostreococcus species, at least one polynucleotide encoding a delta-4-desaturase from Thraustochytrium species or Pavlova species, and at least one recombinant polynucleotide encoding an omega-3-desaturase from Phythophthora species or Pythium species, and wherein expression of said transgenes in said transgenic seed results in said increase in n-3 VLC-PUFAs content and total tocopherol content in said transgenic seed.

2. The transgenic seed of claim 1 , wherein the total tocopherol content of the transgenic seed is more than 35 mg/100 g transgenic seed.

3. The transgenic seed of claim 1 , wherein the total tocopherol content of the transgenic seed is from about 36 mg/100 g transgenic seed to about 44 mg/100 g transgenic seed.

4. The transgenic seed of claim 1 , wherein the content of VLC-PUFAs in the transgenic seed is increased by at least 5%, at least 10%, at least 15%, at least 20%, or at least 30% by the transgenic seed weight as compared to a seed of a wild-type Brassica control plant of the same species and variety.

5. The transgenic seed of claim 1 , wherein the content of VLC-PUFAs in the transgenic seed is increased by 5% to 30% by the transgenic seed weight compared to a seed of a wild-type Brassica control plant of the same species and variety.

6. The transgenic seed of claim 1 , wherein the transgenic seed is from a Brassica plant of the species Brassica napus, Brassica carinata, Brassica juncea, Brassica oleracea, Brassica nigra , or Brassica rapa.

7. The transgenic seed of claim 1 , wherein the total tocopherol content is measured as the numeric average of transgenic seed total tocopherol content of at least 100 transgenic Brassica plants.

8. The transgenic seed of claim 1 , wherein the increased n-3 VLC-PUFAs content comprises DHA and wherein the increased total tocopherol content and the increased DHA content in the transgenic seed are positively correlated.

9. A transgenic seed of a transgenic Brassica plant, the transgenic seed comprising total tocopherol and n-3 very long chain polyunsaturated fatty acids (VLC-PUFAs), wherein the transgenic seed has increased total tocopherol content and increased n-3 VLC-PUFAs content as compared to a seed from a wild-type control Brassica plant of the same species and variety, wherein the increased n-3 VLC-PUFAs content comprises DHA; and wherein the increased total tocopherol content and the increased DHA content in the transgenic seed are positively correlated; wherein the transgenic seed comprises transgenes which comprise at least one recombinant polynucleotide encoding a delta-12-desaturase from Phythophthora species, at least one recombinant polynucleotide encoding a delta-6-desaturase from Ostreococcus species, at least one recombinant polynucleotide encoding a delta-6-elongase from Physcomitrella species or Thalassiosira species, at least one recombinant polynucleotide encoding a delta-5-desaturase from Thraustochytrium species, at least one recombinant polynucleotide encoding a delta-5-elongase from Ostreococcus species, at least one polynucleotide encoding a delta-4-desaturase from Thraustochytrium species or Pavlova species, and at least one recombinant polynucleotide encoding an omega-3-desaturase from Phythophthora species or Pythium species; and wherein expression of said transgenes in said transgenic seed results in said increase in n-3 VLC-PUFAs content and total tocopherol content in said transgenic seed.

10. The transgenic seed of claim 9 , wherein the total tocopherol content of the transgenic seed is more than 35 mg/100 g transgenic seed; and wherein the content of n-3 VLC-PUFAs in the transgenic seed is increased by at least 5%, at least 10%, at least 15%, at least 20%, or at least 30% by transgenic seed weight as compared to seed from a wild-type Brassica control plant of the same species and variety.

11. The transgenic seed of claim 9 , wherein the total tocopherol content of the transgenic seed is from about 36 mg/100 g transgenic seed to about 44 mg/100 g transgenic seed.

12. The transgenic seed of claim 11 , wherein the content of n-3 VLC-PUFAs in the transgenic seed is increased by 5% to 30% by transgenic seed weight as compared to a seed from a wild-type Brassica control plant of the same species and variety.

13. The transgenic seed of claim 9 , wherein the total tocopherol content is measured as the numeric average of transgenic seed total tocopherol content of at least 100 transgenic Brassica plants.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2019
From: ANDRE, CARL
To: BASF PLANT SCIENCE LP
Reel/Frame 049104/0631 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2019
From: BASF PLANT SCIENCE LP
To: BASF PLANT SCIENCE COMPANY GMBH
Reel/Frame 049104/0633 →
Continuity (4)
Continuation 15525768
Provisional Application 62234373 · Sep 29, 2015
Provisional Application 62079622 · Nov 14, 2014
Related Publication 20190256862A1 · Aug 22, 2019
Cited By (2)
US 12,723,251 US 12,723,252